Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of plantar warts located on the bottom of the foot. Plantar warts are characterized by their specific location, tenderness, and disruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and if desired, the wart may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely. If necessary, the medicated patch can be cut to ensure it fits the wart appropriately.

The adhesive side of the patch should then be applied directly onto the wart. To ensure the area is concealed, the medicated patch should be covered with a pad. This procedure may be repeated every 48 hours as needed, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Application is not recommended on irritated, infected, or reddened skin due to the potential for exacerbating these conditions. The product should not be applied to genital warts or warts located on the face, as these areas may have heightened sensitivity and risk of adverse reactions. Additionally, the use is contraindicated on moles, birthmarks, and warts with hair growing from them, as these may indicate underlying conditions that require different management. The product must not be used on mucous membranes, as this could lead to irritation or other complications.

Warnings and Precautions

For external use only. This product is contraindicated for application on irritated, infected, or reddened skin. It should not be used on genital warts, facial warts, moles, birthmarks, or warts with hair growing from them. Additionally, application on mucous membranes is prohibited.

Healthcare professionals should advise patients to consult a doctor prior to use if they have diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects.

Patients are instructed to discontinue use and seek medical advice if discomfort persists.

It is essential to keep this product out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware that the product is intended for external use only. It is contraindicated for application on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. Additionally, the product should not be applied to mucous membranes.

Before using the product, patients with diabetes or poor blood circulation are advised to consult a healthcare professional. If discomfort persists after application, patients should discontinue use and seek medical advice.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (medicated plantar wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The safety of Salicylic Acid during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in this population. Consequently, the potential risks to fetal outcomes remain unclear. Healthcare professionals should exercise caution when considering the use of Salicylic Acid in pregnant patients, as the absence of safety data necessitates a careful assessment of the benefits versus risks. Women of childbearing potential should be advised to discuss their treatment options with their healthcare provider to ensure appropriate management during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the prescribing information regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is essential.

Management procedures should include monitoring vital signs and providing supportive care as needed. In cases where the specific substance is known, appropriate antidotes or treatments should be administered as per established protocols.

It is essential for healthcare providers to remain vigilant and act swiftly to mitigate the potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of the reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the medication on irritated, infected, or reddened skin, as well as on genital warts and warts located on the face. It is important to emphasize that the product should not be applied to moles, birthmarks, or warts with hair growing from them, nor should it be used on mucous membranes.

Healthcare providers should counsel patients to discontinue use and consult a doctor if discomfort persists. Additionally, patients should be encouraged to ask a doctor before using the product if they have diabetes or poor blood circulation, as these conditions may require special consideration.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 15° to 30°C (59° to 86°F) to maintain its efficacy and stability. Proper container requirements should be adhered to, ensuring that the product is kept in a suitable environment. Special handling needs must be observed to prevent any compromise to the product's integrity during storage and transportation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)